Data Insights
No filters selected
No filters selected
No filters selected
No filters selected
WP-1066 by Moleculin Biotech for Brain Tumor: Likelihood of Approval
WP-1066 is under clinical development by Moleculin Biotech and currently in Phase II for Brain Tumor. According to GlobalData, Phase...
WP-1066 by Moleculin Biotech for Metastatic Melanoma: Likelihood of Approval
WP-1066 is under clinical development by Moleculin Biotech and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase...
WP-1066 by Moleculin Biotech for Pediatric Diffuse Intrinsic Pontine Glioma: Likelihood of Approval
WP-1066 is under clinical development by Moleculin Biotech and currently in Phase I for Pediatric Diffuse Intrinsic Pontine Glioma. According...
WP-1066 by Moleculin Biotech for Glioblastoma Multiforme (GBM): Likelihood of Approval
WP-1066 is under clinical development by Moleculin Biotech and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData,...